Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Shared Hospital Services (AMS) Gains from Sales and Divestitures (2020 - 2024)

Historic Gains from Sales and Divestitures for American Shared Hospital Services (AMS) over the last 5 years, with Q4 2024 value amounting to $120000.0.

  • American Shared Hospital Services' Gains from Sales and Divestitures rose 344.83% to $120000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $120000.0, marking a year-over-year increase of 344.83%. This contributed to the annual value of $120000.0 for FY2024, which is 344.83% up from last year.
  • As of Q4 2024, American Shared Hospital Services' Gains from Sales and Divestitures stood at $120000.0, which was up 344.83% from $116000.0 recorded in Q4 2023.
  • In the past 5 years, American Shared Hospital Services' Gains from Sales and Divestitures registered a high of $168000.0 during Q4 2021, and its lowest value of $116000.0 during Q4 2023.
  • Moreover, its 5-year median value for Gains from Sales and Divestitures was $132000.0 (2022), whereas its average is $134000.0.
  • Per our database at Business Quant, American Shared Hospital Services' Gains from Sales and Divestitures skyrocketed by 2537.31% in 2021 and then plummeted by 2142.86% in 2022.
  • Over the past 5 years, American Shared Hospital Services' Gains from Sales and Divestitures (Quarter) stood at $134000.0 in 2020, then rose by 25.37% to $168000.0 in 2021, then fell by 21.43% to $132000.0 in 2022, then decreased by 12.12% to $116000.0 in 2023, then increased by 3.45% to $120000.0 in 2024.
  • Its Gains from Sales and Divestitures stands at $120000.0 for Q4 2024, versus $116000.0 for Q4 2023 and $132000.0 for Q4 2022.